Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

NCT04076748 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Crisis

Interventions

DRUG: Sufentanil
DRUG: EMONO

Sponsor

University Hospital, Bordeaux